StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) stock

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$1.91−0.09 (-4.50%)

Close on Nov 18, 2026Market cap $75.35MP/E –Yield –

Sera Prognostics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Sera Prognostics's gross profit for the twelve months ending Jun 30, 2026 was -$105.00K. For fiscal 2025 it was -$83.00K.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$83.00K–
FY2024Dec 31, 2024-$5.00K-105.2%
FY2023Dec 31, 2023$96.00K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$20.00K–
Q1 FY2026Mar 31, 2026-$28.00K–
Q4 FY2025Dec 31, 2025-$32.00K–
Q3 FY2025Sep 30, 2025-$25.00K-256.3%
Q2 FY2025Jun 30, 2025-$24.00K-700.0%
Q1 FY2025Mar 31, 2025-$2.00K–
Q4 FY2024Dec 31, 2024-$8.00K–
Q3 FY2024Sep 30, 2024$16.00K–
Q2 FY2024Jun 30, 2024$4.00K–
Q1 FY2024Mar 31, 2024-$17.00K–

More Sera Prognostics figures

See a number that looks wrong?